The Coming Shift in AMD Care

Anat Loewenstein, MD, MHA; and Alistair Laidlaw, MBBS, MD

Show Description +

Alistair Laidlaw, MBBS, MD, talks with Anat Loewenstein, MD, MHA, about some of the challenges of anti-VEGF therapy and the solutions that are making their way into the clinic.

Posted: 10/18/2022

Keywords:

Anti-VEGF

•

retina-meeting-recap

•

Age-Related Macular Degeneration (AMD)

Up Next

Name: The Coming Shift in AMD Care
Uploaded: 2022-10-18T14:56:26+00:00
Description: Alistair Laidlaw, MBBS, MD, talks with Anat Loewenstein, MD, MHA, about some of the challenges of anti-VEGF therapy and the solutions that are making their way into the clinic.

Treating Traumatic Aphakia and Aniridia

Matteo Forlini, MD; and Mario R. Romano, MD, PhD

CRISPR/Cas9 Shows Promise for Patients with LCA

Mark E. Pennesi, MD, PHD

Type 1 Neovascularization or CSC?

Dinah Zur, MD; and Anat Loewenstein, MD, MHA

A Word From Euretina's President

Alistair Laidlaw, MBBS, MD

Gearing Up for a GA Therapy

Kourous A. Rezaei, MD; and Anat Loewenstein, MD, MHA

Using AI for DR Screening in India

S. Natarajan, MBBS, DO, FICO (UK), FVRS; and Andrzej Grzybowski, MD, PhD, MBA

Steps to Achieving the Impossible in DR Management

Sobha Sivaprasad, MBBS, MS, DM, FRCS, FRCOphth

Back to All Videos